The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer

被引:21
作者
Onyiba, Cosmos Ifeanyi [1 ]
Scarlett, Christopher J. [2 ,3 ]
Weidenhofer, Judith [1 ,3 ]
机构
[1] Univ Newcastle, Coll Hlth Med & Wellbeing, Sch Biomed Sci & Pharm, Ourimbah, NSW 2258, Australia
[2] Univ Newcastle, Coll Hlth Med & Wellbeing, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia
[3] Hunter Med Res Inst, New Lambton Hts, NSW 2305, Australia
关键词
sirtuins; breast; prostate; cancer; tumor; miRNA; suppression; promotion; progression; metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSIVE ACTIVITY; HISTONE DEACETYLASE; CELL-GROWTH; GLUTAMINE-METABOLISM; INDUCED AUTOPHAGY; EXPRESSION LEVELS; SIRT1; EXPRESSION; C-MYC; INVASION;
D O I
10.3390/cancers14205118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary There are diverse reports of the dual role of sirtuin genes and proteins in breast and prostate cancers. This review discusses the current information on the tumor promotion or suppression roles of SIRT1-7 in breast and prostate cancers. Precisely, we highlight that sirtuins regulate various proteins implicated in proliferation, apoptosis, autophagy, chemoresistance, invasion, migration, and metastasis of both breast and prostate cancer. We also provide evidence of the direct regulation of sirtuins by miRNAs, highlighting the consequences of this regulation in breast and prostate cancer. Overall, this review reveals the potential value of sirtuins as biomarkers and/or targets for improved treatment of breast and prostate cancers. Mammalian sirtuins (SIRT1-7) are involved in a myriad of cellular processes, including apoptosis, proliferation, differentiation, epithelial-mesenchymal transition, aging, DNA repair, senescence, viability, survival, and stress response. In this review, we discuss the current information on the mechanistic roles of SIRT1-7 and their downstream effects (tumor promotion or suppression) in cancers of the breast and prostate. Specifically, we highlight the involvement of sirtuins in the regulation of various proteins implicated in proliferation, apoptosis, autophagy, chemoresistance, invasion, migration, and metastasis of breast and prostate cancer. Additionally, we highlight the available information regarding SIRT1-7 regulation by miRNAs, laying much emphasis on the consequences in the progression of breast and prostate cancer.
引用
收藏
页数:30
相关论文
共 230 条
  • [91] Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer A TARGET FOR PROSTATE CANCER MANAGEMENT VIA ITS INHIBITION?
    Jung-Hynes, Brittney
    Nihal, Minakshi
    Zhong, Weixiong
    Ahmad, Nihal
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (06) : 3823 - 3832
  • [92] The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms
    Kaeberlein, M
    McVey, M
    Guarente, L
    [J]. GENES & DEVELOPMENT, 1999, 13 (19) : 2570 - 2580
  • [93] Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer
    Kala, Rishabh
    Shah, Harsh N.
    Martin, Samantha L.
    Tollefsbol, Trygve O.
    [J]. BMC CANCER, 2015, 15
  • [94] microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy
    Kanchan, Ranjana K.
    Siddiqui, Jawed A.
    Mahapatra, Sidharth
    Batra, Surinder K.
    Nasser, Mohd W.
    [J]. MOLECULAR CANCER, 2020, 19 (01)
  • [95] SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
    Kim, Hyun-Seok
    Vassilopoulos, Athanassios
    Wang, Rui-Hong
    Lahusen, Tyler
    Xiao, Zhen
    Xu, Xiaoling
    Li, Cuiling
    Veenstra, Timothy D.
    Li, Bing
    Yu, Hongtao
    Ji, Junfang
    Wang, Xin Wei
    Park, Seong-Hoon
    Cha, Yong I.
    Gius, David
    Deng, Chu-Xia
    [J]. CANCER CELL, 2011, 20 (04) : 487 - 499
  • [96] SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
    Kim, Hyun-Seok
    Patel, Krish
    Muldoon-Jacobs, Kristi
    Bisht, Kheem S.
    Aykin-Burns, Nukhet
    Pennington, J. Daniel
    van der Meer, Riet
    Nguyen, Phuongmai
    Savage, Jason
    Owens, Kjerstin M.
    Vassilopoulos, Athanassios
    Ozden, Ozkan
    Park, Seong-Hoon
    Singh, Keshav K.
    Abdulkadir, Sarki A.
    Spitz, Douglas R.
    Deng, Chu-Xia
    Gius, David
    [J]. CANCER CELL, 2010, 17 (01) : 41 - 52
  • [97] A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells
    Kojima, Keitaro
    Ohhashi, Riyako
    Fujita, Yasunori
    Hamada, Nanako
    Akao, Yukihiro
    Nozawa, Yoshinori
    Deguchi, Takashi
    Ito, Masafumi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 373 (03) : 423 - 428
  • [98] Anticancer Agents Targeted to Sirtuins
    Kozako, Tomohiro
    Suzuki, Takayoshi
    Yoshimitsu, Makoto
    Arima, Naomichi
    Honda, Shin-ichiro
    Soeda, Shinji
    [J]. MOLECULES, 2014, 19 (12) : 20295 - 20313
  • [99] Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer
    Kugel, Sita
    Feldman, Jessica L.
    Klein, Mark A.
    Silberman, Dafne M.
    Sebastian, Carlos
    Mermel, Craig
    Dobersch, Stephanie
    Clark, Abbe R.
    Getz, Gad
    Denu, John M.
    Mostoslavsky, Raul
    [J]. CELL REPORTS, 2015, 13 (03): : 479 - 488
  • [100] Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1
    Kumar, Parameet
    Sharad, Shashwat
    Petrovics, Gyorgy
    Mohamed, Ahmed
    Dobi, Albert
    Sreenath, Taduru L.
    Srivastava, Shiv
    Biswas, Roopa
    [J]. ONCOTARGET, 2016, 7 (16) : 22791 - 22806